Underrepresentation of blacks, smokers, and obese patients in studies of monoclonal antibodies for asthma
J Allergy Clin Immunol Pract
.
2020 Feb;8(2):739-741.e6.
doi: 10.1016/j.jaip.2019.08.023.
Epub 2019 Aug 28.
Authors
Ayobami Akenroye
1
,
Corinne Keet
2
Affiliations
1
Division of Pediatric Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
2
Division of Pediatric Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: ckeet1@jhmi.edu.
PMID:
31472296
PMCID:
PMC10959542
DOI:
10.1016/j.jaip.2019.08.023
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Antibodies, Monoclonal / therapeutic use
Asthma* / epidemiology
Black or African American
Humans
Obesity / epidemiology
Smokers*
Substances
Antibodies, Monoclonal
Grants and funding
K99 MD015767/MD/NIMHD NIH HHS/United States
R00 MD015767/MD/NIMHD NIH HHS/United States
T32 AI007007/AI/NIAID NIH HHS/United States